Abstract |
Introduction: Coxiella burnetii infection is still challenging physicians, mainly because no international coordination has been stated to standardize the therapeutic strategy and improve the clinical outcomes.Areas covered: Based on the recent knowledge on Q fever, we review here the clinical practices from Q fever diagnosis to therapy. We searched PubMed and Google Scholar to perform the qualitative synthesis.Expert opinion: Four major critical points are highlighted in this review. The first point is that Q fever diagnosis has been reviewed in the light of the new diagnosis tools, including molecular biology, transthoracic echocardiography, and 18F-FDG-PET/CT-scan imaging. Q fever diagnosis results from the presence of a microbiological criterion in addition to a lesional criterion. Second, the identification of the anticardiolipin antibodies as a novel biological predictive marker for acute Q fever complications ( hemophagocytic syndrome, acute Q fever endocarditis, alithiasic cholecystitis, hepatitis, and meningitis). Third, the observation of a coincidence between Q fever and non-Hodgkin lymphoma that has made persistent C. burnetii infection a risk of non-Hodgkin lymphoma. Finally, we expose here the close follow-up we proposed from the French National Reference Center for patients with Q fever infection to detect relapse and complications.
|
Authors | Cléa Melenotte, Matthieu Million, Didier Raoult |
Journal | Expert review of anti-infective therapy
(Expert Rev Anti Infect Ther)
Vol. 18
Issue 1
Pg. 75-86
(01 2020)
ISSN: 1744-8336 [Electronic] England |
PMID | 31782315
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Antibodies, Anticardiolipin
- Fluorodeoxyglucose F18
|
Topics |
- Animals
- Antibodies, Anticardiolipin
(blood)
- Coxiella burnetii
(isolation & purification)
- Echocardiography
- Fluorodeoxyglucose F18
- Humans
- Lymphoma, Non-Hodgkin
(etiology)
- Positron Emission Tomography Computed Tomography
- Q Fever
(complications, diagnosis, microbiology, therapy)
|